glutathione and parkinson's Central nervous system uptake of intranasal in disease glutathione parkinson's A review of

Competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

45 HsiehM

When classifying BPC-157 as a Category 2 substance meaning it cannot be legally used in compounded medications the agency cited specific issues: the potential for immune reactions when a synthetic peptide is injected, difficulties in verifying the purity and composition of the active ingredient, and insufficient safety data for the routes of administration being used [15]

Therapeutic Drug Use

It would indeed reduce pressure at the GP surgery this was part of my discussion